Cited by 110Treatment of Major DepressionElectroconvulsive Therapy StudiesBipolar Disorder and Treatment

The DOI matches its Crossref record; 176 of the 176 references it cites were found in a registry or an index.

Augmentation strategies for treatment-resistant depression: a literature review: Augmentation strategies for TRD

Carvalho, A. F., Cavalcante, J. L., Castelo, M. S., Lima, M. C. O.·2007·Journal of Clinical Pharmacy and Therapeutics

DOI 10.1111/j.1365-2710.2007.00846.x

Open this paper in CoChat — free account

Abstract

BACKGROUND: The large majority of depressed patients fail to remit on the first antidepressant prescribed. These patients with residual symptoms have higher relapse rates and poorer outcomes than those who remit. Treatment-resistant depression (TRD) is a therapeutic challenge for the clinician. Augmentation pharmacotherapy refers to the addition of drugs that are not standard antidepressants in order to enhance the effect of a classical antidepressant drug. The aim of this paper was to review the available evidence on the various augmenting agents that have been tested for efficacy in TRD. METHODS: Electronic databases and relevant textbooks were searched and the information retrieved was integrated in this review. RESULTS: Although augmentation strategies have been tested with various pharmacological agents, there are few controlled studies published. Lithium, triiodothyronine (T3), buspirone and pindolol have been most widely studied. Other agents include dopaminergic agents, atypical antipsychotics, psychostimulants, benzodiazepines/hypnotics, hormones and anticonvulsants. CONCLUSION: The augmentation therapy with the best evidence was the lithium-antidepressant combination, especially in patients not responding to tricyclic agents. However, good results have also been reported with augmentation strategies involving T3 and buspirone.

Integrity signals

Registry

Crossref · 10.1111/j.1365-2710.2007.00846.x

Cites

176 of 176 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus
Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09104.2000 · Cited by 3,111
The Corticosteroid Receptor Hypothesis of Depression
Holsboer, F. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00159-7 · Cited by 2,181
Diagnosis and definition of treatment-resistant depression
Fava, M. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00231-2 · Cited by 1,380
Omega 3 Fatty Acids in Bipolar Disorder: A Preliminary Double-blind, Placebo-Controlled Trial
Stoll, A. L., Severus, W. E., Freeman, M. P., Rueter, S., Zboyan, H. A., Diamond, E., Cress, K. K., & Marangell, L. B. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.5.407 · Cited by 814
Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors
Thase, M. E., Entsuah, A. R., & Rudolph, R. L. (2001) · The British Journal of Psychiatry · doi:10.1192/bjp.178.3.234 · Cited by 801
DEFINITION AND EPIDEMIOLOGY OF TREATMENT-RESISTANT DEPRESSION
Fava, M., & Davidson, K. G. (1996) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70283-5 · Cited by 797
Residual symptoms after partial remission: an important outcome in depression
Paykel, E. S., Ramana, R., Cooper, Z., Hayhurst, H., Kerr, J., & Barocka, A. (1995) · Psychological Medicine · doi:10.1017/s0033291700033146 · Cited by 791
Untitled work
(1997) · PubMed · Cited by 727
Neuropsychopharmacology
Mathur, R. (2004) · Jaypee Brothers Medical Publishers (P) Ltd. eBooks · doi:10.5005/jp/books/10243_6 · Cited by 669
Antipsychotic-Induced Hyperprolactinaemia: Mechanisms, Clinical Features and Management
Haddad, P. M., & Wieck, A. (2004) · Drugs · doi:10.2165/00003495-200464200-00003 · Cited by 634
Is there a role for 5-HT1A agonists in the treatment of depression?
Blier, P., & Ward, N. M. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01643-8 · Cited by 529
Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations
Thase, M. E. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830230043006 · Cited by 515
Central monoamines and their role in major depression
Elhwuegi, A. S. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2003.11.018 · Cited by 513
A Novel Augmentation Strategy for Treating Resistant Major Depression
Shelton, R. C., Tollefson, G. D., Tohen, M. F., Stahl, S. M., Gannon, K. S., Jacobs, T. G., Buras, W. R., Bymaster, F. P., Zhang, W., Spencer, K. A., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.1.131 · Cited by 512
Triiodothyronine Augmentation in the Treatment of Refractory Depression
Aronson, R. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830090090013 · Cited by 488
Treatment-Resistant Depression
Stolerman, I. P., & Price, L. H. (2015) · Springer eBooks · doi:10.1007/978-3-642-36172-2_200431 · Cited by 485
Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder
Fava, M., McCall, W. V., Krystal, A., Wessel, T., Rubens, R., Caron, J., Amato, D., & Roth, T. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.01.016 · Cited by 480
Residual symptoms in depressed patients who respond acutely to fluoxetine
Nierenberg, A. A., Keefe, B. R., Leslie, V. C., Alpert, J. E., Pava, J. A., Worthington, J. J., Rosenbaum, J. F., & Fava, M. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0403 · Cited by 470 · cited 1×
“Depressed patients who do not achieve remission (including those who respond but do not remit) continue to be affected by the psychological, behavioural and somatic symptoms of depression (7, 8).”
Background
Does Incomplete Recovery From First Lifetime Major Depressive Episode Herald a Chronic Course of Illness?
Judd, L. L., Paulus, M. J., Schettler, P. J., Akiskal, H. S., Endicott, J., Leon, A. C., Maser, J. D., Mueller, T., Solomon, D. A., & Keller, M. B. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.9.1501 · Cited by 458
Double-blind treatment of major depression with dehydroepiandrosterone.
Wolkowitz, O. M., Reus, V. I., Keebler, A., Nelson, N., Friedland, M., Brizendine, L., & Roberts, E. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.4.646 · Cited by 411
Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat
Kodama, M., Fujioka, T., & Duman, R. S. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.07.008 · Cited by 387
Are Subjects in Pharmacological Treatment Trials of Depression Representative of Patients in Routine Clinical Practice?
Zimmerman, M., Mattia, J. I., & Posternak, M. A. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.3.469 · Cited by 382
Buprenorphine Treatment of Refractory Depression
Bodkin, J. A., Zornberg, G. L., Lukas, S. E., & Cole, J. O. (1995) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199502000-00008 · Cited by 346
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and Continuation Treatment of Major Depressive Disorder
Bauer, M., Whybrow, P. C., Angst, J., Versiani, M., Möller, H., & WFSBP Task Force on Treatment Guide (2002) · The World Journal of Biological Psychiatry · doi:10.3109/15622970209150599 · Cited by 342
Testosterone Gel Supplementation for Men With Refractory Depression: A Randomized, Placebo-Controlled Trial
Pope, H. G., Cohane, G. H., Kanayama, G., Siegel, A. J., & Hudson, J. I. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.1.105 · Cited by 341
Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial
Coppen, A., & Bailey, J. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00153-1 · Cited by 337
Lithium Augmentation in Treatment-Resistant Depression: Meta-Analysis of Placebo-Controlled Studies
Bauer, M., & Döpfmer, S. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199910000-00006 · Cited by 301
Estrogen Replacement and Response to Fluoxetine in a Multicenter Geriatric Depression Trial
Schneider, L. S. S., Small, G. W., Hamilton, S. H., Bystritsky, A., Nemeroff, C. B., & Meyers, B. S. (1997) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-199700520-00002 · Cited by 297
Lithium Carbonate Augmentation of Antidepressant Treatment
Heninger, G. R. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790110077013 · Cited by 286
Antidepressant activity of non-competitive and competitive NMDA receptor antagonists in a chronic mild stress model of depression
Papp, M., & Moryl, E. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90516-9 · Cited by 272
Efficacy and Safety of Second-Generation Antidepressants in the Treatment of Major Depressive Disorder
Hansen, R. A., Gartlehner, G., Lohr, K. N., Gaynes, B. N., & Carey, T. S. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-6-200509200-00006 · Cited by 260
A Placebo-Controlled Comparison of Lithium and Triiodothyronine Augmentation of Tricyclic Antidepressants in Unipolar Refractory Depression
Joffe, R. T. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820170065008 · Cited by 257
Does thyroid supplementation accelerate tricyclic antidepressant response? A review and meta-analysis of the literature
Altshuler, L. L., Bauer, M., Frye, M. A., Gitlin, M. J., Mintz, J., Szuba, M. P., Leight, K. L., & Whybrow, P. C. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.10.1617 · Cited by 250
Risperidone Augmentation of Selective Serotonin Reuptake Inhibitors in Major Depression
Ostroff, R. B., & Nelson, J. C. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0410 · Cited by 248
Enhancement of the antidepressant action of fluoxetine by folic acid: A randomised, placebo controlled trial
Coppen, A. J., & Bailey, J. (2000) · PsycEXTRA Dataset · doi:10.1037/e323122004-002 · Cited by 236
Treatment-resistant depression
Souery, D., Papakostas, G. I., & Trivedi, M. H. (2006) · Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) · Cited by 231
Atypical neuroleptics stimulate neurogenesis in adult rat brain
Wakade, C. G., Mahadik, S. P., Waller, J. L., & Chiu, F. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10281 · Cited by 230
Prospective controlled studies of the behavioral and biological effects of exogenous corticosteroids
Wolkowitz, O. M. (1994) · Psychoneuroendocrinology · doi:10.1016/0306-4530(94)90064-7 · Cited by 222
Treatment-Resistant Depression
MORGAN, P. T. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000270085.15253.15 · Cited by 218
Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled study
D, M. F. M., Rosenbaum, J. F., McGrath, P. J., Stewart, J. W., Amsterdam, J. D., & Quitkin, F. M. (1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.9.1372 · Cited by 216
A Multicenter, Placebo-Controlled Study of Modafinil Augmentation in Partial Responders to Selective Serotonin Reuptake Inhibitors With Persistent Fatigue and Sleepiness
D, M. F. M., Thase, M. E., & DeBattista, C. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0112 · Cited by 209
A "new" blood-group character related to the ABO system. 1952.
Bhende, Y. M., Deshpande, C. K., Bhatia, H. M., Sanger, R. A., Race, R. R., Morgan, W. T. J., & Watkins, W. M. (2008) · PubMed · Cited by 208
Modafinil Augmentation of Antidepressant Treatment in Depression
Menza, M. A., Kaufman, K. R., & Castellanos, A. M. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0510 · Cited by 200
Adjunct Modafinil for the Short-Term Treatment of Fatigue and Sleepiness in Patients With Major Depressive Disorder
DeBattista, C., Doghramji, K., Menza, M. A., Rosenthal, M. H., Fieve, R. R., & Modafinil in Depression Study Group (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0911 · Cited by 190
New Drugs for Insomnia
Terzano, M. G., Rossi, M., Palomba, V., Smerieri, A., & Parrino, L. (2003) · Drug Safety · doi:10.2165/00002018-200326040-00004 · Cited by 181
Zolpidem for Persistent Insomnia in SSRI-Treated Depressed Patients
Asnis, G. M., Chakraburtty, A., DuBoff, E. A., Krystal, A., Londborg, P. D., Rosenberg, R., Roth-Schechter, B., Scharf, M. B., & Walsh, J. K. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n1005 · Cited by 176
A Double-Blind, Placebo-Controlled Study of Citalopram With and Without Lithium in the Treatment of Therapy-Resistant Depressive Patients
Baumann, P., Nil, R., Souché, A., Montaldi, S., Baettig, D., Lambert, S., Uehlinger, C., Kasas, A., Amey, M., & Jonzier-Perey, M. (1996) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199608000-00006 · Cited by 176
Double-Blind, Placebo-Controlled Trial of the Use of Lithium to Augment Antidepressant Medication in Continuation Treatment of Unipolar Major Depression
Bauer, M., Bschor, T., Kunz, D., Berghöfer, A., Ströhle, A., & Müller-Oerlinghausen, B. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.9.1429 · Cited by 175
Antiglucocorticoid treatment of depression: double-blind ketoconazole
Wolkowitz, O. M., Reus, V. I., Chan, T., Manfredi, F., Raum, W. J., Johnson, R., & Canick, J. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00267-4 · Cited by 165
A double-blind, randomized, placebo-controlled trial of augmentation with lamotrigine or placebo in patients concomitantly treated with fluoxetine for resistant major depressive episodes
Barbosa, L., Berk, M., & Vorster, M. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0407 · Cited by 165
Pathophysiology of antipsychotic drug-induced movement disorders.
Casey, D. E. (2004) · PubMed · Cited by 158
Placebo-Controlled Trial of Lithium Augmentation of Fluoxetine and Lofepramine
Katona, C., Abou‐Saleh, M. T., Harrison, D. A., Nairac, B. L., Edwards, D. R. L., Lock, T., Burns, R. A., & Robertson, M. M. (1995) · The British Journal of Psychiatry · doi:10.1192/bjp.166.1.80 · Cited by 158
A comparison of triiodothyronine and thyroxine in the potentiation of tricyclic antidepressants
Joffe, R. T., & Singer, W. (1990) · Psychiatry Research · doi:10.1016/0165-1781(90)90029-5 · Cited by 156
Patients With Severe Depression May Benefit From Buspirone Augmentation of Selective Serotonin Reuptake Inhibitors
Appelberg, B., Syvälahti, E. K. G., Koskinen, T., Mehtonen, O. ‐., Muhonen, T. T., & Naukkarinen, H. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n0608 · Cited by 153
Pramipexole Augmentation in the Treatment of Unipolar and Bipolar Depression: A Retrospective Chart Review
Sporn, J., Ghaemi, S. N., Sambur, M. R., Rankin, M. A., Recht, J., Sachs, G. S., Rosenbaum, J. F., & D, M. F. M. (2000) · Annals of Clinical Psychiatry · doi:10.1023/a:1009060800999 · Cited by 153
Estrogen Replacement Therapy and Antidepressant Response to Sertraline in Older Depressed Women
Schneider, L. S. S., Small, G. W., & Clary, C. M. (2001) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200111000-00007 · Cited by 151
Current Status of Augmentation and Combination Treatments for Major Depressive Disorder: A Literature Review and a Proposal for a Novel Approach to Improve Practice
D, M. F. M., & Rush, A. J. (2006) · Psychotherapy and Psychosomatics · doi:10.1159/000091771 · Cited by 151
Estrogen replacement therapy in the treatment of major depressive disorder in perimenopausal women.
Rasgon, N., Altshuler, L. L., Fairbanks, L. A., Dunkin, J. J., Davtyan, C., Elman, S., & Rapkin, A. J. (2002) · PubMed · Cited by 150
Pramipexole in treatment‐resistant depression: a 16‐week naturalistic study
Lattanzi, L., Dell’Osso, L., Cassano, P., Pini, S., Rucci, P., Houck, P. R., Gemignani, A., Battistini, G., Bassi, A., Abelli, M., et al. (2002) · Bipolar Disorders · doi:10.1034/j.1399-5618.2002.01171.x · Cited by 150
A Randomized, Double-Blind, Placebo-Controlled Trial of Buspirone in Combination With an SSRI in Patients With Treatment-Refractory Depression
Landén, M., Björling, G., Agren, H., & Fahlén, T. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n1204 · Cited by 149
Ziprasidone Augmentation of Selective Serotonin Reuptake Inhibitors (SSRIs) for SSRI-Resistant Major Depressive Disorder
Papakostas, G. I., Petersen, T., Nierenberg, A. A., Murakami, J. L., Alpert, J. E., Rosenbaum, J. F., & D, M. F. M. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0212 · Cited by 148
Nutrition and depression: focus on folate
Alpert, J. E., Mischoulon, D., Nierenberg, A. A., & D, M. F. M. (2000) · Nutrition · doi:10.1016/s0899-9007(00)00327-0 · Cited by 148
A Prospective Trial of Modafinil as an Adjunctive Treatment of Major Depression
DeBattista, C., Lembke, A., Solvason, H. B., Ghebremichael, R., & Poirier, J. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000104910.75206.b9 · Cited by 144
Effectiveness of pindolol plus serotonin uptake inhibitors in depression: a meta-analysis of early and late outcomes from randomised controlled trials
Ballesteros, J., & Callado, L. F. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00404-4 · Cited by 138
A Potential Clinical Use for Methylphenidate with Tricyclic Antidepressants
Wharton, R. N., Perel, J. M., Dayton, P. G., & Malitz, S. (1971) · American Journal of Psychiatry · doi:10.1176/ajp.127.12.1619 · Cited by 134
Folinic Acid (Leucovorin) as an Adjunctive Treatment for SSRI-Refractory Depression
Alpert, J. E., Mischoulon, D., Rubenstein, G., Bottonari, K. A., Nierenberg, A. A., & D, M. F. M. (2002) · Annals of Clinical Psychiatry · doi:10.3109/10401230209147396 · Cited by 134
Partial Response, Nonresponse, and Relapse With Selective Serotonin Reuptake Inhibitors in Major Depression
Fredman, S. J., D, M. F. M., Kienke, A. S., White, C. N., Nierenberg, A. A., & Rosenbaum, J. F. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0602 · Cited by 133
Double-Blind Study of High-Dose Fluoxetine Versus Lithium or Desipramine Augmentation of Fluoxetine in Partial Responders and Nonresponders to Fluoxetine
D, M. F. M., Alpert, J. E., Nierenberg, A. A., Lagomasino, I. T., Sonawalla, S. B., Tedlow, J. R., Worthington, J. J., Baer, L., & Rosenbaum, J. F. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200208000-00008 · Cited by 131
Methylphenidate augmentation of serotonin selective reuptake inhibitors: a case series.
Stoll, A. L., Pillay, S. S., Diamond, L., Workum, S. B., & Cole, J. O. (1996) · PubMed · Cited by 130
Treatment of Major Depression with metyrapone and hydrocortisone
O’Dwyer, A.-M., Lightman, S. L., Marks, M. N., & Checkley, S. A. (1995) · Journal of Affective Disorders · doi:10.1016/0165-0327(94)00082-k · Cited by 127
Response to Steroid Suppression in Major Depression
Murphy, B. E. P., Dhar, V., GHADIRIAN, A. M., Chouinard, G., & KELLER, R. (1991) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199104000-00009 · Cited by 126
Potential mechanisms of action of atypical antipsychotic medications in treatment-resistant depression and anxiety.
Blier, P., & Szabo, S. T. (2005) · PubMed · Cited by 125
Aripiprazole Augmentation of Selective Serotonin Reuptake Inhibitors for Treatment-Resistant Major Depressive Disorder
Papakostas, G. I., Petersen, T., Kinrys, G., Burns, A. M., Worthington, J. J., Alpert, J. E., D, M. F. M., & Nierenberg, A. A. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n1017 · Cited by 125
Fluoxetine efficacy in menopausal women with and without estrogen replacement
Amsterdam, J. D., García‐España, F., Fawcett, J., Quitkin, F. M., Reimherr, F. W., Rosenbaum, J. F., & Beasley, C. M. (1999) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00203-1 · Cited by 123
Aripiprazole as an augmentor of selective serotonin reuptake inhibitors in depression and anxiety disorder patients
Worthington, J. J., Kinrys, G., Wygant, L. E., & Pollack, M. H. (2004) · International Clinical Psychopharmacology · doi:10.1097/00004850-200501000-00002 · Cited by 120
CNS Stimulant Potentiation of Monoamine Oxidase
FAWCETT, J. A., Kravitz, H. M., Zajecka, J., SCHAFF, M. R., & FREISHTAT, H. W. (1991) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199104000-00010 · Cited by 118
Lithium Augmentation Therapy in Tricyclic-Resistant Depression
Stein, G. S., & Bernadt, M. (1993) · The British Journal of Psychiatry · doi:10.1192/bjp.162.5.634 · Cited by 118
Pramipexole Augmentation in the Treatment of Unipolar and Bipolar Depression: A Retrospective Chart Review
Sporn, J., Ghaemi, S. N., Sambur, M. R., et al. (2000) · Annals of Clinical Psychiatry · doi:10.3109/10401230009147102 · Cited by 118
An open study of buspirone augmentation of serotonin reuptake inhibitors in refractory depression.
Joffe, R. T., & Schuller, D. R. (1993) · PubMed · Cited by 112
EICOSAPENTAENOIC ACID IN TREATMENT‐RESISTANT DEPRESSION ASSOCIATED WITH SYMPTOM REMISSION, STRUCTURAL BRAIN CHANGES AND REDUCED NEURONAL PHOSPHOLIPID TURNOVER
Puri, B. K., Counsell, S. J., Hamilton, G., Richardson, A. J., & Horrobin, D. F. (2001) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2001.tb11122.x · Cited by 110
Abnormalities of glucose metabolism associated with atypical antipsychotic drugs.
Newcomer, J. W. (2004) · PubMed · Cited by 109
Adjunctive Dopamine Agonists in Treatment-Resistant Bipolar II Depression: an Open Case Series
Perugi, G., Toni, C., Ruffolo, G., Frare, F., & Akiskal, H. S. (2001) · Pharmacopsychiatry · doi:10.1055/s-2001-15872 · Cited by 108
Evaluating antidepressant therapies: remission as the optimal outcome.
Thase, M. E. (2003) · PubMed · Cited by 107
Lamotrigine as Adjunct to Paroxetine in Acute Depression
Normann, C., Hummel, B., Schärer, L. O., Horn, M., Grunze, H., & Walden, J. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0411 · Cited by 107
Combined MAOI, TCA, and direct stimulant therapy of treatment-resistant depression.
Feighner, J. P., Herbstein, J., & Damlouji, N. F. (1985) · PubMed · Cited by 105
S-Adenosyl-L-Methionine (SAMe) as an Adjunct for Resistant Major Depressive Disorder
Alpert, J. E., Papakostas, G. I., Mischoulon, D., Worthington, J. J., Petersen, T., Mahal, Y., Burns, A. M., Bottiglieri, T., Nierenberg, A. A., & D, M. F. M. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000145339.45794.cd · Cited by 105
Amantadine as augmentation therapy in the management of treatment-resistant depression
Stryjer, R., Strous, R. D., Shaked, G., Bar, F., Feldman, B., Kotler, M., Polak, L., Rosenzcwaig, S., & Weizman, A. (2003) · International Clinical Psychopharmacology · doi:10.1097/00004850-200303000-00005 · Cited by 103
Treatment Augmentation With Opiates in Severe and Refractory Major Depression
Stoll, A. L., & Rueter, S. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.12.2017 · Cited by 102
Treatment strategy in depression
Nolen, W. A., van de Putte, J. J., Dijken, W. A., Kamp, J. S., Blansjaar, B. A., Kramer, H., & Haffmans, J. (1988) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1988.tb06403.x · Cited by 93
Acute and maintenance treatment of chronic depression.
Dünner, D. L. (2001) · PubMed · Cited by 92
T3 augmentation of SSRI resistant depression
Abraham, G., Milev, R. V., & Lawson, J. S. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.01.013 · Cited by 90
Lithium Augmentation Increases the ACTH and Cortisol Response in the Combined DEX/CRH Test in Unipolar Major Depression,
Bschor, T. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00323-8 · Cited by 84
Lack of efficacy of estrogen supplementation to imipramine in resistant female depressives
Shapira, B., Oppenheim, G., Zohar, J., Segal, M. S., Malach, D., & Belmaker, R. H. (1985) · Biological Psychiatry · doi:10.1016/0006-3223(85)90031-9 · Cited by 84
Dexamethasone augmentation in treatment‐resistant depression
Dinan, T. G., Lavelle, E., Cooney, J., Burnett, F., Scott, L. V., Dash, A. R., Thakore, J. H., & Berti, C. (1997) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1997.tb00374.x · Cited by 83
Possible augmentation of antidepressant response by buspirone.
Jacobsen, F. M. (1991) · PubMed · Cited by 82
Eicosapentaenoic Acid in Treatment-Resistant Depression
Puri, B. K., Counsell, S. J., Richardson, A. J., & Horrobin, D. F. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.1.91-a · Cited by 82
Strategies for Managing Depression Refractory to Selective Serotonin Reuptake Inhibitor Treatment: A Survey of Clinicians
Mischoulon, D., Nierenberg, A. A., Kizilbash, L., Rosenbaum, J. F., & D, M. F. M. (2000) · The Canadian Journal of Psychiatry · doi:10.1177/070674370004500509 · Cited by 81
The psychotropic effects of inhibitors of steroid biosynthesis in depressed patients refractory to treatment
GHADIRIAN, A. M., Engelsmann, F. F., Dhar, V., Filipini, D., Keller, R., Chouinard, G., & Murphy, B. E. P. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(94)00150-2 · Cited by 80
Treatment of Endogenous Depressions Resistant to Tricyclic Antidepressants or Related Drugs by Lithium Addition. Results of a Placebo-Controlled Double-Blind Study
Schöpf, J., Baumann, P., Lemarchand, T., & Rey, M. (1989) · Pharmacopsychiatry · doi:10.1055/s-2007-1014603 · Cited by 80
Safety and Efficacy of Testosterone Gel 1% Augmentation in Depressed Men With Partial Response to Antidepressant Therapy
Orengo, C. A., Fullerton, L., & Kunik, M. E. (2005) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988704271767 · Cited by 79
Treatment strategy in depression
Nolen, W. A., van de Putte, J. J., Dijken, W. A., Kamp, J. S., Blansjaar, B. A., Kramer, H., & Haffmans, J. (1988) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1988.tb06402.x · Cited by 74
Efficacy of S-adenosyl-L-methionine in speeding the onset of action of imipramine
Berlanga, C., Ortega-Soto, H. A., Ontiveros, M., & Sentíes, H. (1992) · Psychiatry Research · doi:10.1016/0165-1781(92)90029-3 · Cited by 73
Efficacy and Mechanisms of Action of Lithium Augmentation in Refractory Major Depression
Bschor, T., & Bauer, M. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206777947650 · Cited by 72
Adjunctive Modafinil at Initiation of Treatment With a Selective Serotonin Reuptake Inhibitor Enhances the Degree and Onset of Therapeutic Effects in Patients With Major Depressive Disorder and Fatigue
Ninan, P. T., Hassman, H. A., Glass, S., & McManus, F. C. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0318 · Cited by 72
Buspirone Augmentation of Antidepressant Therapy
Dimitriou, E. C., & Dimitriou, C. E. (1998) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199812000-00009 · Cited by 70
Intramuscular Testosterone Supplementation to Selective Serotonin Reuptake Inhibitor in Treatment-Resistant Depressed Men
Seidman, S. N., Miyazaki, M., & Roose, S. P. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000185424.23515.e5 · Cited by 70
Remission versus response: the new gold standard of antidepressant care.
Keller, M. B. (2004) · PubMed · Cited by 69
Is extended clonazepam cotherapy of fluoxetine effective for outpatients with major depression?
Smith, W. T., Londborg, P. D., Glaudin, V., & Painter, J. R. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00352-4 · Cited by 68
RESPONSE TO BROMOCRIPTINE DISTINGUISHES BIPOLAR FROM UNIPOLAR DEPRESSION
Silverstone, T. (1984) · The Lancet · doi:10.1016/s0140-6736(84)91359-x · Cited by 66
The antidepressant potential of oral S‐adenosyl‐l‐methionine*
Rosenbaum, J. F., D, M. F. M., Falk, W. E., Pollack, M. H., Cohen, L. S., Cohen, B. M., & Zubenko, G. S. (1990) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1990.tb05476.x · Cited by 66
High Dose Tranylcypromine Therapy for Refractory Depression
Amsterdam, J. D., & Berwish, N. J. (1989) · Pharmacopsychiatry · doi:10.1055/s-2007-1014572 · Cited by 64
An Open Study of Triiodothyronine Augmentation of Selective Serotonin Reuptake Inhibitors in Treatment-Resistant Major Depressive Disorder
Iosifescu, D. V., Nierenberg, A. A., Mischoulon, D., Perlis, R. H., Papakostas, G. I., Ryan, J. L., Ryan, J. L., Alpert, J. E., & D, M. F. M. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0812 · Cited by 64
The Benefit of Lithium Carbonate Adjunct in Refractory Depression — Fact or Fiction?
Kantor, D., Mcnevin, S., Leichner, P. P., Harper, D., & Krenn, M. J. (1986) · The Canadian Journal of Psychiatry · doi:10.1177/070674378603100506 · Cited by 63
Adjunct low dose lithium carbonate in treatment-resistant depression: a placebo-controlled study.
Zusky, P. M., Biederman, J., Rosenbaum, J. F., Manschreck, T. C., Gross, C. C., Weilberg, J. B., & Gastfriend, D. R. (1988) · PubMed · Cited by 63
Basic psychopharmacology of antidepressants, part 2: Estrogen as an adjunct to antidepressant treatment.
Stahl, S. M. (1998) · PubMed · Cited by 63
Clomipramine, Tryptophan and Lithium in Combination for Resistant Endogenous Depression: Seven Case Studies
Hale, A. S., PROCTER, A. W., & Bridges, P. K. (1987) · The British Journal of Psychiatry · doi:10.1192/bjp.151.2.213 · Cited by 61
Modafinil Augmentation of SSRI Therapy in Patients with Major Depressive Disorder and Excessive Sleepiness and Fatigue: A 12-Week, Open-label, Extension Study
Thase, M. E., D, M. F. M., DeBattista, C., Arora, S., & Hughes, R. J. (2006) · CNS Spectrums · doi:10.1017/s1092852900010622 · Cited by 61
Major depressive disorder: remission of associated symptoms.
Trivedi, M. H. (2006) · PubMed · Cited by 60
Treatment of antidepressant nonresponders: augmentation or switch?
Nelson, J. C. (1998) · PubMed · Cited by 60
Preliminary experience with adjunctive quetiapine in patients receiving selective serotonin reuptake inhibitors
Adson, D. E., Kushner, M. G., Eiben, K. M., & Schulz, S. C. (2004) · Depression and Anxiety · doi:10.1002/da.10137 · Cited by 59
Use and misuse of benzodiazepines in Brazil: a review
Kapczinski, F., Amaral, O. B., Madruga, M., Quevedo, J., Busnello, J. V., & de Lima, M. S. (2001) · Substance Use & Misuse · doi:10.1081/ja-100104489 · Cited by 57
Self-citation
Effectiveness and Safety of Benzodiazepines
Möller, H. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199912002-00002 · Cited by 56
Psychostimulant augmentation of second generation antidepressants: A case series
Masand, P. S., Anand, V. S., & Tanquary, J. F. (1998) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1998)7:2 · Cited by 54
Residual Symptoms in Depressed Patients After Treatment With Fluoxetine or Reboxetine
Nelson, J. C., Portera, L., & Leon, A. C. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n1110 · Cited by 52
Adjunct Low Dose Lithium Carbonate in Treatment-Resistant Depression
Zusky, P. M., Biederman, J., Rosenbaum, J. F., Manschreck, T. C., Gross, C. C., Weilberg, J. B., & Gastfriend, D. R. (1988) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198804000-00007 · Cited by 52
Algorithm-based treatment of major depression in an outpatient clinic: clinical correlates of response to a specific serotonin reuptake inhibitor and to triiodothyronine augmentation
Agid, O., & Lerer, B. (2003) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114570200322x · Cited by 51
Lithium in Tricyclic-Resistant Depression Correlation of Increased Brain 5-HT Function with Clinical Outcome
Cowen, P. J., McCance, S., Ware, C., Cohen, P. R., Chalmers, J. S., & Julier, D. (1991) · The British Journal of Psychiatry · doi:10.1192/bjp.159.3.341 · Cited by 50
Pindolol Augmentation in Depressed Patients Resistant to Selective Serotonin Reuptake Inhibitors
Perry, E. B., Berman, R., Sanacora, G., Anand, A., Lynch-Colonese, K., & Charney, D. S. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0215 · Cited by 49
Bromocriptine in affective disorders
Colonna, L., Petit, M., & Lépine, J. (1979) · Journal of Affective Disorders · doi:10.1016/0165-0327(79)90002-8 · Cited by 47
Antiglucocorticoid treatment of refractory depression with ketoconazole: A case report
Anand, A., Malison, R. T., McDougle, C. J., & Price, L. H. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(94)00245-x · Cited by 46
Modafinil augmentation in depressed patients with partial response to antidepressants: A pilot study on self-reported symptoms covered by the Major Depression Inventory (MDI) and the Symptom Checklist (SCL-92)
Rasmussen, N.-A., Schrøder, P., Olsen, L. R., Brødsgaard, M., Undén, M., & Bech, P. (2005) · Nordic Journal of Psychiatry · doi:10.1080/08039480510023025 · Cited by 46
Pindolol augmentation of antidepressant treatment: recent contributions from brain imaging studies
Martínez, D., Broft, A. I., & Laruelle, M. A. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00993-8 · Cited by 46
Gradual Discontinuation of Lithium Augmentation in Elderly Patients With Unipolar Depression
Hardy, B. G., Shulman, K. I., & Zucchero, C. (1997) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199702000-00005 · Cited by 46
Pergolide: an antidepressant adjuvant for mood disorders?
Bouckoms, A. J., & Mangini, L. (1993) · PubMed · Cited by 46
Basic Mechanisms of Augmentation of Antidepressant Effects with Thyroid Hormone
Lifschytz, T., Segman, R. H., Shalom, G., Lerer, B., Gur, E., Golzer, T., & Newman, M. E. (2006) · Current Drug Targets · doi:10.2174/138945006775515482 · Cited by 45
Modulation of glutamate receptors: Strategies for the development of novel antidepressants
Skolnick, P. (2002) · Amino Acids · doi:10.1007/s00726-001-0121-7 · Cited by 43
Mood stabilizer augmentation in apparently “unipolar” MDD: predictors of response in the naturalistic French national EPIDEP study
Hantouche, E. G., Akiskal, H. S., Lancrenon, S., & Châtenet-Duchêne, L. (2004) · Journal of Affective Disorders · doi:10.1016/j.jad.2004.01.006 · Cited by 42
Inositol addition does not improve depression in SSRI treatment failures
Nemets, B., Mishory, A., Levine, J., & Belmaker, R. H. (1999) · Journal of Neural Transmission · doi:10.1007/s007020050200 · Cited by 42
Hypnotics as concurrent medication in depression
Nolen, W. A., Haffmans, P. M. J., Bouvy, P. F., & Duivenvoorden, H. J. (1993) · Journal of Affective Disorders · doi:10.1016/0165-0327(93)90103-q · Cited by 41
Discontinuation of lithium augmentation in an elderly cohort
Fahy, S. T., & LAWLOR, B. A. (2001) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.453 · Cited by 37
L-5HTP in Depression Resistant to Re-Uptake Inhibitors
Nolen, W. A., van de Putte, J. J., Dijken, W. A., & Kamp, J. J. H. (1985) · The British Journal of Psychiatry · doi:10.1192/bjp.147.1.16 · Cited by 37
Adjunctive gabapentin in treatment-resistant depression: a retrospective chart review
Yasmin, S., Carpenter, L. L., Leon, Z., Siniscalchi, J. M., & Price, L. H. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00187-7 · Cited by 36
Treatment of a refractory depression with a combination of fluoxetine and d-amphetamine
Linet, L. S. (1989) · American Journal of Psychiatry · doi:10.1176/ajp.146.6.803b · Cited by 36
Pharmacologic Management of Difficult-to-Treat Depression in Clinical Practice
Fleck, M. P., & Horwath, E. (2005) · Psychiatric Services · doi:10.1176/appi.ps.56.8.1005 · Cited by 35
Metabolic and Endocrine Disturbances in Psychiatric Disorders: A Multidisciplinary Approach to Appropriate Atypical Antipsychotic Utilization
Masand, P. S., Culpepper, L., Henderson, D. C., Lee, S., Littrell, K. H., Newcomer, J. W., & Rasgon, N. (2005) · CNS Spectrums · doi:10.1017/s1092852900025499 · Cited by 33
Carbamazepine addition in tricyclic antidepressant-resistant unipolar depression
FUENTE, J. M. D. L., & Mendlewicz, J. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90041-w · Cited by 31
Multicenter double-blind randomized parallel-group clinical trial of efficacy of the combination clomipramine (150 mg/day) plus lithium carbonate (750 mg/day) versus clomipramine (150 mg/day) plus placebo in the treatment of unipolar major depression
Januel, D. (2003) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00086-1 · Cited by 30
An Open-Label Trial of Modafinil Augmentation in Patients with Partial Response to Antidepressant Therapy
Markovitz, P. J., & Wagner, S. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200304000-00017 · Cited by 30
Potentiation strategies for treatment‐resistant depression
Ros, S., Agüera, L., de la Gándara, J., Rojo, E., & de Pedro, J. M. (2005) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2005.00676.x · Cited by 29
Carbamazepine augmentation therapy in three patients with trazodone-resistant unipolar depression
Otani, K., Yasui, N., Kaneko, S., Ohkubo, T., Osanai, T., & Sugawara, K. (1996) · International Clinical Psychopharmacology · doi:10.1097/00004850-199603000-00008 · Cited by 27
Lithium augmentation increases post-dexamethasone cortisol in the dexamethasone suppression test in unipolar major depression
Bschor, T., Baethge, C., Adli, M., Eichmann, U., Ising, M., Uhr, M., Müller-Oerlinghausen, B., & Bauer, M. (2003) · Depression and Anxiety · doi:10.1002/da.10078 · Cited by 27
Special issues related to the treatment of depression in women.
Yonkers, K. A. (2003) · PubMed · Cited by 26
Lithium as an Adjunct in the Treatment of Major Depression
BROWNE, M., Lapierre, Y. D., Hrdina, P. D., & HORN, E. (1990) · International Clinical Psychopharmacology · doi:10.1097/00004850-199004000-00004 · Cited by 25
Combination of Fluoxetine with Pemoline in the Treatment of Major Depressive Disorder
Metz, A. L., & Shader, R. I. (1991) · International Clinical Psychopharmacology · doi:10.1097/00004850-199100620-00003 · Cited by 23
Pharmacological mechanisms of T3 augmentation of antidepressant action
Newman, M. E., Agid, O., Gur, E., & Lerer, B. (2000) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145700001875 · Cited by 23
Disfunções mínimas da tiróide: hipotiroidismo subclínico e hipertiroidismo subclínico
Romaldini, J. H., Sgarbi, J. A., & Farah, C. S. (2004) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302004000100016 · Cited by 22
Hypnotics: An update
Roehrs, T., & Roth, T. G. (2003) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-003-0074-1 · Cited by 22
Treatment for Therapy-Resistant Depression
Kielholz, P. (2010) · Psychopathology · doi:10.1159/000285154 · Cited by 22
Effects of joint administration of imipramine and amantadine in patients with drug-resistant unipolar depression.
Rogóż, Z., Dziedzicka‐Wasylewska, M., Daniel, W. A., Wójcikowski, J., Dudek, D., Wróbel, A., & Zięba, A. (2004) · PubMed · Cited by 22
Identification of Treatment-Resistant Depressives Who Respond Favorably to Carbamazepine
Varney, N. R., Garve, M., Cook, B. L., Campbell, D., & Roberts, R. (1993) · Annals of Clinical Psychiatry · doi:10.3109/10401239309148973 · Cited by 20
Addition of estrogen to imipramine in female-resistant depressives.
Zohar, J., Shapira, B., Oppenheim, G., Fj, A., & Belmaker, R. H. (1985) · PubMed · Cited by 20
Clinical use of ketoconazole in hypercortisoluric depressives
Ravaris, C. L., Brinck‐Johnsen, T., & Elliott, B. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)90888-5 · Cited by 10
The Efficacy of Lithium in Prophylaxis of Unipolar Depression Evidence from its Discontinuation
Souza, F. G. M., Mander, A. J., & Goodwin, G. M. (1990) · The British Journal of Psychiatry · doi:10.1192/bjp.157.5.718 · Cited by 10
Early onset of antidepressant action: impact on primary care.
Culpepper, L. (2001) · PubMed · Cited by 10
Metanalysis of olanzapine-fluoxetine use in treatment-resistant depression
Dubé, S., Andersen, S. W., Paul, S. M., Corya, S. A., Campen, L. E. V., Sanger, T. M., Welge, L., Nanos, J., & Tollefson, G. D. (2002) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(02)80145-6 · Cited by 7
Dexamethasone for Depression
Wolkowitz, O. M., Reus, V. I., Manfredi, F., Chan, T., Ormiston, S., & Johnson, R. C. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.8.1112 · Cited by 7
Omega-3 fatty acids and augmentation strategies in treating resistant depression.
Nemets, B., Osher, Y., & Belmaker, R. H. (2004) · PubMed · Cited by 6
Dexamethasone for Depression
Mitchell, A. J. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.8.1111-a · Cited by 4
Pharmacologie Expérimentale et Clinique des Psychostimulants
Bourin, M., Mellédo, J. L., & Malinge, M. (1995) · The Canadian Journal of Psychiatry · doi:10.1177/070674379504000707 · Cited by 4
Misuse and Abuse of Benzodiazepines
Ciccone, P. E. (1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.9.1246 · Cited by 4
Primer in Folic Acid: Folates and Neuropsychiatry
Abalan, F. (1999) · Nutrition · doi:10.1016/s0899-9007(99)00115-x · Cited by 3
Misuse and abuse of benzodiazepines
Ciccone, P. E. (1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.9.aj14491246 · Cited by 3
OF TREATMENT-RESISTANT DEPRESSION
Cowen, P. J. (2005) · Cited by 3
[Recent aspects of biological treatment of depression].
Pöldinger, W. (1990) · PubMed · Cited by 2
Treatment-refractory depression: Definitions and characteristics
Berman, R. M., Narasimhan, M., & Charney, D. S. (1997) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1997)5:4

Research works printed but not linked: 1

Dunner, 2003, Adjunctive ziprasidone in treatment-resident depression: a pilot study

Sorted by citations

Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: A systematic review
Berger, W., Mendlowicz, M. V., Marques-Portella, C., Kinrys, G., Fontenelle, L. F., Marmar, C. R., & Figueira, I. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.12.004 · Cited by 347
Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants
Browne, C. A., & Lucki, I. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00161 · Cited by 285
Serotonergic Drugs for Depression and Beyond
Stahl, S. M., Lee-Zimmerman, C., Cartwright, S., & Morrissette, D. A. (2013) · Current Drug Targets · doi:10.2174/1389450111314050007 · Cited by 273
Cognitive remission: a novel objective for the treatment of major depression?
Bortolato, B., Miskowiak, K. W., Köhler, C. A., Maes, M., Fernandes, B. S., Berk, M., & Carvalho, A. F. (2016) · BMC Medicine · doi:10.1186/s12916-016-0560-3 · Cited by 252
Self-citation
Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study
Siwek, M., Dudek, D., Paul, I. A., Sowa-Kućma, M., Zięba, A., Popik, P., Pilc, A., & Nowak, G. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.02.014 · Cited by 210

See all 110

Authors: Carvalho, A. F., Cavalcante, J. L., Castelo, M. S., & Lima, M. C. O.
Affiliations: Universidade Federal do Ceará (BR)
Henry Ford Health (US)
ORCID: Carvalho, A. F.
Cavalcante, J. L.
Lima, M. C. O.
Venue: Journal of Clinical Pharmacy and Therapeutics
Publisher: Wiley
Published: 2007-09-14
Volume: 32
Issue: 5
Pages: 415-428
ISSN: 0269-4727 (ISSN-L)
1365-2710
DOI: 10.1111/j.1365-2710.2007.00846.x
OpenAlex: W1623415077
Cited by: 110
References: 176
Citations by year: 2026: 1 · 2025: 1 · 2024: 7 · 2023: 3 · 2022: 7 · 2021: 5 · 2020: 4 · 2019: 8 · 2018: 2 · 2017: 3 · 2016: 8 · 2015: 6 · 2014: 10 · 2013: 12 · 2012: 10
FWCI: 0.77
Type: journal article
Language: en
Open access: closed
Licence: doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 2909 d)
Locations: Journal of Clinical Pharmacy and Therapeutics (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
Keywords: treatment-resistant depression, augmentation therapy, antidepressant augmentation, lithium, triiodothyronine, buspirone, pindolol, atypical antipsychotics, psychostimulants, benzodiazepines, antiepileptic drugs, tricyclic antidepressants, residual depressive symptoms
MeSH terms: Central Nervous System Stimulants, Anticonvulsants, Antidepressive Agents, Benzodiazepines, Buspirone, Depressive Disorder, Drug Resistance, Drug Synergism, Drug Therapy, Combination, Humans, Hypnotics and Sedatives, Pindolol, Antipsychotic Agents, Triiodothyronine, Dopamine Agents, Lithium Compounds

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Augmentation strategies for treatment-resistant depression: a literature review: Augmentation strategies for TRD

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks